Labigen S.A.S. Company Profile - Ecuador | Financials & Key Executives

Labigen S.A.S. (Ecuador)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Support Activities for Animal Production | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Testing Laboratories | Other Scientific and Technical Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences | Research and Development in Nanotechnology | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Veterinary Services | Medical and Diagnostic Laboratories

Full name: Labigen S.A.S.

Profile Updated: June 27, 2024

Labigen S.A.S. is based in Ecuador. The head office is in Quito. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on March 11, 2021. It currently has a total number of 21 (2023) employees. From the latest financial highlights, Labigen S.A.S. reported a net sales revenue increase of 260.51% in 2023. There was a total negative growth of 32.75% in Labigen S.A.S.’s total assets over the same period.

Headquarters
Av 12 de Octubre, Urban Plaza Bldg. , Floor 10
Quito; Pichincha;

Contact Details: Purchase the Labigen S.A.S. report to view the information.

Website: http://www.labigen.com

Basic Information

Total Employees:

Purchase the Labigen S.A.S. report to view the information.

Outstanding Shares:

Purchase the Labigen S.A.S. report to view the information.

Registered Capital:

Purchase the Labigen S.A.S. report to view the information.

Incorporation Date:

March 11, 2021

Key Executives

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Labigen S.A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net sales revenue

260.51%▲

Total operating revenue

260.59%▲

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total assets

-32.75%▼

Total equity

N/A

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

66.55%▲

Debt to Equity Ratio

N/A

Quick Ratio

0.93%▲

Cash Ratio

0.22%▲

Similar companies